chr1-160278080-T-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000368072.10(PEX19):c.*1471A>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00333 in 702,516 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0018 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 28 hom. )
Consequence
PEX19
ENST00000368072.10 3_prime_UTR
ENST00000368072.10 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.421
Genes affected
PEX19 (HGNC:9713): (peroxisomal biogenesis factor 19) This gene is necessary for early peroxisomal biogenesis. It acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. These disorders have at least 14 complementation groups, with more than one phenotype being observed for some complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause of Zellweger syndrome (ZWS), as well as peroxisome biogenesis disorder complementation group 14 (PBD-CG14), which is also known as PBD-CGJ. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 1-160278080-T-A is Benign according to our data. Variant chr1-160278080-T-A is described in ClinVar as [Benign]. Clinvar id is 874148.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.0018 (274/152298) while in subpopulation EAS AF= 0.0268 (139/5186). AF 95% confidence interval is 0.0232. There are 4 homozygotes in gnomad4. There are 142 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PEX19 | NM_002857.4 | c.*1471A>T | 3_prime_UTR_variant | 8/8 | ENST00000368072.10 | NP_002848.1 | ||
PEX19 | NM_001193644.1 | c.*1479A>T | 3_prime_UTR_variant | 8/8 | NP_001180573.1 | |||
PEX19 | NR_036492.2 | n.2270A>T | non_coding_transcript_exon_variant | 7/7 | ||||
PEX19 | NR_036493.2 | n.2294A>T | non_coding_transcript_exon_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PEX19 | ENST00000368072.10 | c.*1471A>T | 3_prime_UTR_variant | 8/8 | 1 | NM_002857.4 | ENSP00000357051 | P1 | ||
PEX19 | ENST00000472750.5 | c.*2138A>T | 3_prime_UTR_variant, NMD_transcript_variant | 7/7 | 1 | ENSP00000434633 | ||||
PEX19 | ENST00000467711.5 | n.119+51A>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00182 AC: 277AN: 152180Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
277
AN:
152180
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00555 AC: 726AN: 130796Hom.: 4 AF XY: 0.00423 AC XY: 302AN XY: 71408
GnomAD3 exomes
AF:
AC:
726
AN:
130796
Hom.:
AF XY:
AC XY:
302
AN XY:
71408
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00375 AC: 2064AN: 550218Hom.: 28 Cov.: 0 AF XY: 0.00318 AC XY: 946AN XY: 297842
GnomAD4 exome
AF:
AC:
2064
AN:
550218
Hom.:
Cov.:
0
AF XY:
AC XY:
946
AN XY:
297842
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00180 AC: 274AN: 152298Hom.: 4 Cov.: 32 AF XY: 0.00191 AC XY: 142AN XY: 74462
GnomAD4 genome
AF:
AC:
274
AN:
152298
Hom.:
Cov.:
32
AF XY:
AC XY:
142
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
28
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Peroxisome biogenesis disorder 12A (Zellweger) Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at